This trial will help determine if transfusions of older red cells increase rates of infection in adults with Sickle Cell Disease.
- Sickle Cell Disease
1 Primary · 0 Secondary · Reporting Duration: through fourth transfusion, an average of 24 weeks
Side Effects for
Awards & Highlights
2 Treatment Groups
≤10 day Blood
1 of 2
≥30 day Blood
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: Transfusion · No Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 16 - 60 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Which types of people are eligible to volunteer for this research?
"This particular research study is in need of 40 individuals that have sickle cell anemia and meet the following age, transfusion, and hemoglobin requirements: 16 to 60 years old, currently receiving red blood cell transfusions chronically, and have Hemoglobin SS/Hemoglobin Sβ-thalassemia^0." - Anonymous Online Contributor
Will this clinical research be testing treatments on elderly participants?
"The age bracket for patients that this trial is recruiting falls between 16 and 60 years old." - Anonymous Online Contributor
Are recruiting efforts for this experiment ongoing?
"This study, as reported on clinicaltrials.gov, is looking for patients to participate. The trial was originally posted on 10/4/2017 and last edited on 2/28/2022." - Anonymous Online Contributor
Out of how many applicants will this clinical trial choose participants?
"That is correct, the trial detailed on clinicaltrials.gov is presently looking for 40 individuals at 2 locations. The listing was first published on October 4th, 2017 with the most recent update being February 28th, 2022." - Anonymous Online Contributor